1047P Tocilizumab is an Effective Secondary Prophylaxis During Immune Checkpoint Inhibitor Rechallenge Following Arthritis
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined